S.Amdt. 3700

SA 3700. Ms. HASSAN submitted an amendment intended to be proposed by
her to the concurrent resolution S. Con. Res. 14, setting forth the
congressional budget for the United States Government for fiscal year
2022 and setting forth the appropriate budgetary levels for fiscal
years 2023 through 2031; which was ordered to lie on the table; as
follows:

At the end of title III, add the following:

SEC. 3___. RESERVE FUND RELATING TO INCREASING DRUG REBATE
TRANSPARENCY UNDER MEDICARE PART D.

The Chairman of the Committee on the Budget of the Senate
may revise the allocations of a committee or committees,
aggregates, and other appropriate levels in this resolution,
and make adjustments to the pay-as-you-go ledger, for one or
more bills, joint resolutions, amendments, amendments between
the Houses, motions, or conference reports relating to
increasing drug pricing transparency, which may include
requiring mandatory reporting and public disclosure of all
rebates, discounts, price concessions, and formulary
placements for any covered part D drug for which such
rebates, discounts, or price concessions are passed to
beneficiaries at the point of sale, by the amounts provided
that such legislation would not increase the deficit over the
period of the total of fiscal years 2022 through 2031.
______